The proportions of patients with elevated ALT, elevated AST, HBV DNA < 7 x104copies/ml, moderate to severe inflammation, and moderate to severe liver fibrosis were significantly greater among patients with liver disease compared to patients without liver disease (all P≤0.001). This evidence concerns the gene GPT and Hepatic fibrosis.